ESWI event

ESWI webinar series 2021

How can countries cope with more than one major respiratory virus spreading, while non- pharmaceutical interventions are being loosened week by week?

What about:

  • The possible co-circulation of influenza viruses, SARS-CoV-2, and RSV?
  • Who belongs to high risk groups?
  • Who to vaccinate and against what?
  • Guidelines and regulations for co-vaccination?
  • Forecasts on vaccine development?
  • The use of anti-virals and antibodies during different stages of the respective infections?

Each of these challenges have been addressed in our 2021 ESWI Webinar Series.